Equities research analysts predict that Stericycle Inc (NASDAQ:SRCL) will announce sales of $802.91 million for the current fiscal quarter, Zacks Investment Research reports. Seven analysts have provided estimates for Stericycle’s earnings. The lowest sales estimate is $791.00 million and the highest is $812.27 million. Stericycle posted sales of $852.70 million during the same quarter last year, which suggests a negative year-over-year growth rate of 5.8%. The company is scheduled to report its next quarterly earnings report on Thursday, February 27th.
On average, analysts expect that Stericycle will report full-year sales of $3.32 billion for the current fiscal year, with estimates ranging from $3.30 billion to $3.33 billion. For the next financial year, analysts forecast that the business will post sales of $3.32 billion, with estimates ranging from $3.24 billion to $3.41 billion. Zacks’ sales calculations are a mean average based on a survey of analysts that that provide coverage for Stericycle.
Stericycle (NASDAQ:SRCL) last issued its earnings results on Thursday, October 31st. The business services provider reported $0.80 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.68 by $0.12. The business had revenue of $833.10 million during the quarter, compared to the consensus estimate of $842.21 million. Stericycle had a negative net margin of 13.26% and a positive return on equity of 10.52%. Stericycle’s revenue was down 2.6% on a year-over-year basis. During the same period last year, the business posted $1.03 EPS.
NASDAQ:SRCL opened at $65.71 on Friday. Stericycle has a 12-month low of $34.36 and a 12-month high of $66.28. The firm has a market capitalization of $5.99 billion, a price-to-earnings ratio of 14.77, a P/E/G ratio of 2.99 and a beta of 1.27. The stock’s 50 day moving average price is $59.84 and its two-hundred day moving average price is $50.09. The company has a quick ratio of 0.94, a current ratio of 0.94 and a debt-to-equity ratio of 1.19.
In related news, EVP Daniel Ginnetti sold 6,000 shares of Stericycle stock in a transaction that occurred on Thursday, October 31st. The stock was sold at an average price of $55.47, for a total transaction of $332,820.00. Following the completion of the sale, the executive vice president now directly owns 15,943 shares of the company’s stock, valued at approximately $884,358.21. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 2.30% of the stock is currently owned by company insiders.
A number of hedge funds and other institutional investors have recently modified their holdings of SRCL. Bank of New York Mellon Corp boosted its stake in shares of Stericycle by 4.9% in the second quarter. Bank of New York Mellon Corp now owns 923,897 shares of the business services provider’s stock valued at $44,116,000 after buying an additional 43,112 shares during the period. Earnest Partners LLC lifted its holdings in shares of Stericycle by 20.6% in the second quarter. Earnest Partners LLC now owns 414,326 shares of the business services provider’s stock worth $19,784,000 after acquiring an additional 70,892 shares during the last quarter. Callodine Capital Management LP lifted its holdings in shares of Stericycle by 52.3% in the second quarter. Callodine Capital Management LP now owns 220,872 shares of the business services provider’s stock worth $10,547,000 after acquiring an additional 75,872 shares during the last quarter. Texas Permanent School Fund boosted its stake in shares of Stericycle by 6.8% in the 3rd quarter. Texas Permanent School Fund now owns 62,020 shares of the business services provider’s stock valued at $3,159,000 after purchasing an additional 3,940 shares in the last quarter. Finally, Northern Trust Corp boosted its stake in shares of Stericycle by 3.7% in the 2nd quarter. Northern Trust Corp now owns 880,250 shares of the business services provider’s stock valued at $42,031,000 after purchasing an additional 31,193 shares in the last quarter.
Stericycle Company Profile
Stericycle, Inc, together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally. It operates through three segments: Domestic and Canada Regulated Waste and Compliance; International Regulated Waste and Compliance; and Domestic Communication and Related Services.
Further Reading: What is the Russell 2000 Index?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.